Search Results 561-570 of 15124 for alt

1. A Study of the Safety, Tolerability, and Effectiveness of GS-9674 for Adults with Primary Sclerosing Cholangitis without Cirrhosis - Mayo Clinic

   Alanine aminotransferase (ALT) > 10 x ULN; Total bilirubin > 2 x ULN; International normalized ratio (INR) > 1.2 unless on anticoagulant therapy; Small-duct ...

2. A Study to Evaluate Chemotherapy and Radiation Therapy With or Without Surgery to Treat Patients With Head and Neck Cancer - Mayo Clinic

   AST or ALT < 2 x the upper limit of normal;; serum creatinine < 1.5 mg/dl, creatinine clearance > 50 ml/min;; normal serum calcium (or normal corrected serum ...

3. A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Sclerosing Cholangitis (PSC) - Mayo Clinic

   Exceeding pre-defined biochemical values for alanine aminotransferase/aspartate aminotransferase (ALT/AST), estimated glomerular filtration rate (eGFR),serum ...

4. SC16LD6.5 in Recurrent Small Cell Lung Cancer - Mayo Clinic

   AST/ALT (SGOT/SGPT) < 2.5 x ULN for the reference laboratory or < 5 x ULN in the presence of liver metastases; Serum creatinine < 1.5 x ULN. No 'active' CNS ...

5. A Study to Evaluate Fostamatinib Disodium to Treat Warm Antibody Autoimmune Hemolytic Anemia - Mayo Clinic

   ... [ALT] or aspartate aminotransferase [AST]) > 1.5 x ULN. Has documented active hepatitis B or hepatitis C infection or HIV infection. Participating Mayo ...

6. Alisertib With or Without Fulvestrant in Treating Patients With Locally Advanced or Metastatic, Endocrine-Resistant Breast Cancer - Mayo Clinic

   NOTE: If total bilirubin is out of range then direct bilirubin must be ≤ULN. Alanine transaminase (ALT) 2.5 x ULN (5 x ULN for patients with liver involvement); ...

7. Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease - Mayo Clinic

   AST and ALT must be < 2.5 x ULN for the lab. Adequate renal function within 28 days before study entry defined as serum creatinine ≤ 1.5 x ULN for the lab ...

8. A Study of AG-946 in Participants With Anemia Due to Lower-Risk Myelodysplastic Syndromes (LR-MDS) - Mayo Clinic

   ... (ALT) \>2.5 × ULN (unless due to hepatic iron deposition) * Serum bilirubin \>ULN, if the elevation is associated with clinically symptomatic ...

9. Efficacy of Riluzole in Surgical Treatment for Cervical Spondylotic Myelopathy (CSM-Protect) - Mayo Clinic

   ... (ALT or AST) 3x higher than normal values at screening visit. Liver enzymes (ALT or AST) 3x higher than normal values at screening visit. Subject will be ...

10. Efficacy and Safety Study of Mepolizumab in Subjects With Severe Hypereosinophilic Syndrome (HES) - Mayo Clinic

    Liver abnormality/disease - Alanine transaminase (ALT) >2.5x upper limit of normal (ULN) or ALT>5xULN if documented HES with liver manifestations, or ...